tranexamic acid has been researched along with Cancer of Spleen in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlitter, MC | 1 |
| Rühl, H | 1 |
| Thiesler, T | 1 |
| Penner, AH | 1 |
| Berens, C | 1 |
| Wolf, D | 1 |
| Mayer, K | 1 |
| Páramo, JA | 1 |
| Cuesta, B | 1 |
| Aranda, A | 1 |
| Rocha, E | 1 |
2 other studies available for tranexamic acid and Cancer of Spleen
| Article | Year |
|---|---|
Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma.
Topics: Blood Component Transfusion; Chest Pain; Combined Modality Therapy; Disseminated Intravascular Coagu | 2014 |
[Treatment of severe coagulopathy in the Kasabach-Merritt syndrome].
Topics: Adult; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Female; Hemangioma; Huma | 1986 |